Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
ECNP 2021
ECNP 2021
10:05
Treating restless leg syndrome: the present and the future
Diego Garcia-Borreguero
• 30 Sep 2021
5:10
Daridorexant: a breakthrough for insomnia treatment in Europe?
Diego Garcia-Borreguero
• 30 Sep 2021
17:01
Dual orexin receptor antagonists – the story so far and daridorexant Phase III data
Diego Garcia-Borreguero
• 30 Sep 2021
1:41
The Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act
Charles Wilcox
• 28 Sep 2021
2:09
Sleep as a link between the brain and the gut
Liborio Parrino
• 27 Sep 2021
4:11
Neuropsychiatric symptoms in Alzheimer’s disease
João Massano
• 29 Sep 2021
4:36
A2A antagonist improves dopaminergic function and reduces neuroinflammation in a rodent model of PD
Kavya Prasad
• 24 Sep 2021
4:02
Insomnia management: where are current strategies falling short?
Liborio Parrino
• 27 Sep 2021
5:22
Recognizing atypical Alzheimer’s disease
João Massano
• 29 Sep 2021
2:00
Treating caregivers with respect
Charles Wilcox
• 28 Sep 2021
3:30
Orexin receptor antagonists for the treatment of insomnia
Liborio Parrino
• 27 Sep 2021
4:41
Diversity and discrimination: holding back the Alzheimer’s disease fight
Charles Wilcox
• 28 Sep 2021
6:09
The global burden of insomnia
Liborio Parrino
• 27 Sep 2021